Evgen Pharma eyes initial results from Covid-19 trial in Q2 2021
Drug development company Evgen Pharma said the clinical trial evaluating its Covid-19 drug candidate SFX-01 was cleared to continue after a data safety monitoring committee...
Thu, 11/03/2021 - 09:43